A chemogenomic approach seems indispensable for effective treatment of amyotrophic lateral sclerosis
Georgios Pampalakis1*, Georgios Angelis1, Pinelopi Kastana1, Kostas Vekrellis2, Georgia Sotiropoulou3
1Department of Pharmacology-Pharmacognosy, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, 541 24, Greece
2Biomedical Research Foundation, Academy of Athens, 4 Soranou Ephessiou Str, 115 27, Athens, Greece
3Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, 265 04, Greece
*Corresponding author
Tel: 2310 997638
E-mail: gpampalakis@pharm.auth.gr